MIPS
MIPS, a GlobalFoundries subsidiary, licenses RISC-V processor IP cores and NPUs for physical AI applications in automotive ADAS, robotics, and embedded edge computing. Major design wins include Mobileye's EyeQ6 powering 75% of the ADAS market and ForwardEdge ASIC for defense.
- Company typePrivate
- Founded-
- HeadquartersHighlands Ranch, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What MIPS does
MIPS is a semiconductor intellectual property (IP) company specializing in RISC-V processor architectures for physical AI applications at the autonomous edge. The company was acquired by GlobalFoundries (NASDAQ:GFS) in July 2024 and operates as a wholly-owned subsidiary, positioned within GlobalFoundries' vertically integrated physical AI platform that pairs processor IP with mature-node manufacturing. MIPS has completed a strategic pivot from its legacy MIPS instruction set architecture to RISC-V; its eighth-generation products are entirely RISC-V-based and focused on physical AI workloads in autonomous vehicles, robotics, and embedded edge computing. GlobalFoundries has further announced (January 2026) its acquisition of Synopsys' ARC Processor IP Solutions business to combine with MIPS, consolidating two established RISC architecture lineages under one parent.
MIPS's product portfolio includes the S8200 RISC-V neural processing unit (NPU) for AI inference at the edge, the P8700 six-core cluster scalable up to 64-way replication (768 threads) for high-performance processing, the I8500 multithreaded data movement processor, and the M8500 processor architecture for safety-certified microcontrollers. The company offers reference platforms including the MIPS Atlas Explorer simulation environment, a robotics control reference platform co-developed with Inova Semiconductors, and a Safety SDK with Green Hills Software targeting ASIL-D and SIL 3/4 certifications. Named design wins include Mobileye's EyeQ6 processor — powering 75% of the ADAS market across 1,200 vehicle models from 50 global OEMs — and ForwardEdge ASIC, a Lockheed Martin subsidiary, for mission-critical aerospace and defense applications.
MIPS operates as an IP licensing business, generating revenue through licensing fees and royalties paid by semiconductor companies and SoC designers who integrate MIPS RISC-V cores and NPUs into their own chip designs. Pricing is quote-based and negotiated per customer per project; no public pricing or standalone MIPS revenue is disclosed. Distribution is direct to enterprise customers, with go-to-market executed through industry events (RISC-V Summit, Chiplet Summit, Embedded World, GlobalFoundries Technology Summits), reference platforms co-developed with ecosystem partners (Arteris, Inova, Green Hills), and GlobalFoundries' manufacturing customer network. Note: a data conflict exists in the firmographics, which describe MIPS as a medical practice (Minimally Invasive Procedure Specialists in Highlands Ranch, CO) sharing the same name; this analysis is based on the predominant body of evidence describing the semiconductor IP company.
MIPS firmographics
Firmographics- Name
- MIPS
- Legal name
- MIPS
- Website
- https://mipscenter.com
- Company type
- Private
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- MIPS, a GlobalFoundries subsidiary, licenses RISC-V processor IP cores and NPUs for physical AI applications in automotive ADAS, robotics, and embedded edge computing. Major design wins include Mobileye's EyeQ6 powering 75% of the ADAS market and ForwardEdge ASIC for defense.
- Ownership category
- akta.pro rank
MIPS industry classification
Industry- Product category
- Interventional Radiology
- NAICS
- Freestanding Ambulatory Surgical and Emergency Centers (621493)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based) (HLAFABAK)
- akta.pro secondary industries
- Obstetrics & Gynecology (OB/GYN) Clinics (HLAFAJAA), Minimally Invasive Gynecologic Surgery (Laparoscopy/Hysteroscopy) (HLAKAJAF)
Keywords
Where MIPS is headquartered
LocationHeadquarters
- HQ city
- Highlands Ranch
- HQ country
- United States
- HQ region
- North America
Markets served
MIPS business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others, Technology or R&D
Revenue model
- Processor IP Licensing: MIPS licenses its RISC-V processor IP cores to semiconductor companies and system-on-chip designers. Customers integrate MIPS IP into their own chip designs, paying licensing fees and royalties.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
MIPS product offering
Product offeringCore offering
MIPS (Minimally Invasive Procedure Specialists) is an interventional radiology clinic in Highlands Ranch, Colorado that provides minimally invasive, image-guided treatments for chronic vascular and pelvic conditions including pelvic congestion syndrome, uterine fibroids, varicocele, varicose veins, spider veins, and deep vein thrombosis (DVT). The practice operates a state-of-the-art outpatient interventional suite and has treated patients from all 50 U.S. states and 8 countries.
Product overview
MIPS, a GlobalFoundries company acquired in July 2024, offers a portfolio of RISC-V processor IP and platforms for physical AI applications. The company has completed its strategic pivot from legacy MIPS instruction set architecture to entirely RISC-V-based eighth-generation products. Core offerings include the S8200 RISC-V NPU for neural processing, P8700 multi-core cluster architecture, and I8500 data movement processor. These are complemented by platforms including the MIPS Atlas Explorer simulation environment, safety-certified microcontroller solutions via the Safety SDK, and robotics reference platforms. The products target automotive (including ADAS), robotics, industrial, and communications infrastructure markets, with key customers including Mobileye and ForwardEdge ASIC.
Differentiator
Problem solved
Functional benefit
Products and services
- Pelvic Pain Treatment (Pelvic Congestion Syndrome) Image-guided, minimally invasive treatment for women with chronic pelvic pain caused by venous insufficiency (pelvic congestion syndrome). Targets often undiagnosed venous causes of pelvic pain and offers treatments less invasive than traditional surgeries.
- Uterine Fibroid Embolization Minimally invasive, image-guided procedure to treat uterine fibroids by blocking blood flow to fibroid tissue. Performed by interventional radiologists as an alternative to open surgery.
- Varicocele Embolization Image-guided embolization procedure to treat varicocele (enlarged veins in the scrotum), performed as a minimally invasive alternative to surgical ligation.
- Varicose Vein Treatment Minimally invasive, image-guided treatment of varicose veins performed by vascular specialists in an outpatient setting.
- Spider Vein Treatment Treatment for spider veins (a subset of varicose veins) offered as part of the practice's vein care services.
- DVT (Blood Clots) Treatment Minimally invasive, image-guided treatment for deep vein thrombosis (DVT), including blood clot removal and venous stent placement.
- Telehealth Services Remote consultation services enabling patients to access MIPS specialists without traveling to the Highlands Ranch clinic; supports initial consultations and follow-up visits.
Quantifiable outcome
- EyeQ6 processor powering 75% of ADAS market across 1,200 vehicle models from 50 global OEMs
Companies that use MIPS
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
MIPS technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
MIPS partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and flagship.
- Arteris Inc.coreStrategic collaboration to accelerate development of next-generation SoC platforms for physical AI applications. MIPS integrates Arteris' FlexGen Smart Network-on-Chip IP and Magillem SoC Integration Automation Software into its RISC-V processor-based platforms. The partnership addresses key industry challenges including data movement bottlenecks, physical design complexity, and time-to-market pressures for AI-enabled devices targeting automotive, robotics, and embedded computing markets. This partnership builds on collaboration centered on high-performance RISC-V SoCs that began in 2024.
- Green Hills SoftwarecorePartnership to develop Safety Software Development Kit (Safety SDK) for RISC-V microcontrollers, combining MIPS' M8500 processor architecture with Green Hills' certified development tools and RTOS. The jointly developed toolkit is designed to help manufacturers achieve highest functional safety certifications including ASIL-D for automotive systems and SIL 3/4 for industrial applications. Targeting markets including electric vehicle control, power conversion, motor control, and industrial robotics. Companies are gathering requirements from early access customers.
- Inova SemiconductorscoreCollaboration to create a new robotics control reference platform for physical AI systems, combining MIPS' RISC-V-based processors with Inova's high-speed data communication technology. The platform is designed as a custom SoC solution supporting the full sense-think-act-communicate chain for advanced robotic systems. Manufactured using GlobalFoundries' FDX process platform. Companies showcased the platform at Embedded World 2026 in Nuremberg, Germany. Early access provided through MIPS Atlas Explorer simulation environment.
- GlobalFoundriesflagshipMIPS is a subsidiary of GlobalFoundries, acquired in July 2024. GlobalFoundries acquired Synopsys' ARC Processor IP Solutions business to integrate with MIPS, creating a vertically integrated physical AI platform offering both manufacturing and IP licensing through mature technology nodes.
Scale indicators4 records
Recent moves8 records
Expansion highlights6 records
MIPS competitors and assessment
Company assessmentBroad incumbents
- Cleveland Clinic Heart, Vascular & Thoracic Institute: Major academic vascular and interventional medicine program. Represents the broad incumbent alternative where complex venous and vascular cases are typically referred for hospital-based care.
- Mayo Clinic Vascular Center: Destination academic vascular program providing the full spectrum of vascular and interventional radiology care. Sets the clinical benchmark MIPS competes against for complex patient referrals.
Direct peers
- USA Vein Clinics: Outpatient clinic chain specializing in the treatment of venous insufficiency and varicose veins. Competes with MIPS for vein-treatment patients across multiple states under a similar office-based procedural model.
- RIA Endovascular Clinic: Interventional radiology practice focused on venous disease and minimally invasive vascular procedures. Most directly comparable peer — Dr. Spencer previously served as Medical Director here, and the model (outpatient IR destination clinic) closely mirrors MIPS Center.
- Center for Vein Restoration: Largest U.S. network dedicated to the treatment of venous insufficiency, with 100+ locations. Closest scaled analog offering outpatient vein treatment in a multi-site clinic model, competing for similar patient demographics and procedure mix.
- Fibroid Centers: Specialty clinic network dedicated to non-surgical fibroid treatment including uterine fibroid embolization. Directly comparable specialty outpatient procedural model targeting a major MIPS service line.
- Inovia Vein Specialty Centers: Specialty vein clinic chain (formerly Vein Clinics of America) offering outpatient treatment of venous disease. Comparable outpatient procedural model and patient profile to MIPS Center's vein practice.
- Total Vein & Vascular: Independent vascular specialty practice offering outpatient treatment for varicose veins, pelvic congestion, and venous disease. Closely comparable single-specialty procedural model with similar referral-driven patient acquisition.
Others
- Society of Interventional Radiology: Professional medical society for interventional radiologists. Relevant as the industry body that shapes clinical standards, training pipelines, and reimbursement advocacy affecting specialty IR practices like MIPS Center.
Emerging players
- Advanced Interventional Radiology Consultants: Independent IR practices offering outpatient embolization and vascular procedures. Comparable niche specialty procedural model, though typically with broader procedure mix than MIPS's venous focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
MIPS social profiles
Digital presenceMIPS financial estimates
Financial estimateRevenue estimate
Valuation estimate
MIPS leadership team
Management profileNumber of profiles
Profiles4 records
MIPS funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MIPS M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MIPS
What does MIPS do?
MIPS (Minimally Invasive Procedure Specialists) is an interventional radiology clinic in Highlands Ranch, Colorado that provides minimally invasive, image-guided treatments for chronic vascular and pelvic conditions including pelvic congestion syndrome, uterine fibroids, varicocele, varicose veins, spider veins, and deep vein thrombosis (DVT). The practice operates a state-of-the-art outpatient interventional suite and has treated patients from all 50 U.S. states and 8 countries.
Is MIPS a public or private company?
MIPS is a private company. It is classified as founder individual operated bootstrapped and is currently acquired.
When was MIPS founded?
MIPS was founded in -1. It employs 11 to 50 people.
Where is MIPS based?
MIPS is headquartered in Highlands Ranch, United States, in the North America region.
How does MIPS make money?
One revenue line is on record: processor IP Licensing.
Who are MIPS's main competitors?
Broad incumbents on record are Cleveland Clinic Heart, Vascular & Thoracic Institute and Mayo Clinic Vascular Center. Direct peers are USA Vein Clinics, RIA Endovascular Clinic, Center for Vein Restoration, Fibroid Centers, Inovia Vein Specialty Centers and Total Vein & Vascular. Society of Interventional Radiology is listed as an others. Advanced Interventional Radiology Consultants is listed as an emerging player.
Does MIPS have an API?
No public API is recorded for MIPS.
What industry is MIPS in?
MIPS's product category is Interventional Radiology. Its primary akta.pro industry code is HLAFABAK, Ambulatory Cardiology Diagnostic & Procedure Centers (Non-hospital-based), with a secondary code of HLAFAJAA, Obstetrics & Gynecology (OB/GYN) Clinics. Its NAICS code is 621493 and its SIC code is 8093.